Advanced Precision Treatment for Renal Cell Carcinoma

CAIX (CA9) Targeted Therapy for Metastatic Kidney Cancer

About CAIX (CA9) Targeted Therapy

CAIX (Carbonic Anhydrase IX/CA9) is highly expressed in clear-cell renal cell carcinoma and minimally present in normal tissues, making it an ideal target for imaging and therapy. In CAIX-targeted theranostics, a radioactive molecule binds to CAIX on tumor cells after injection, delivering targeted radiation. This enables precise treatment while minimizing damage to healthy tissue, offering a promising option for advanced kidney cancer.

Who Can Benefit from CAIX Targeted Therapy?

CAIX-based therapy may be suitable for patients with:

01. Metastatic Renal Cell Carcinoma

Patients whose kidney cancer has spread to other parts of the body such as:
1. Lungs
2. Bones
3. Liver
4. Lymph nodes
5. Brain

Cancer That Has Progressed After Standard Treatments

02. Cancer That Has Progressed After Standard Treatments

Patients whose cancer continues to grow despite treatments such as:
1. Targeted therapies (TKIs like sunitinib, pazopanib, cabozantinib)
2. Immunotherapy (nivolumab, pembrolizumab)
3. Combination immunotherapy regimens

03. Tumors Showing CAIX Expression

Before treatment, patients may undergo a CAIX PET/CT scan. This scan helps determine whether the tumor expresses the CAIX protein. If the tumor shows uptake on the scan, it indicates that CAIX-targeted therapy may be effective.

04. Progressive Disease

Patients whose cancer is progressing despite ongoing treatment may benefit from CAIX-directed therapy.

How Does CAIX Targeted Therapy Work?

What Does the Treatment Involve?

Simple Intravenous Injection

The therapy is administered through an IV injection, usually completed within 2–3 hours.

Post-Treatment Observation

Patients may stay for a short observation period after the injection. In some cases, post-therapy imaging is performed to see treatment distribution.

How Should I Prepare for the Therapy?

Before starting CAIX-targeted therapy, patients undergo several evaluations, including:

These steps help ensure that the therapy is safe and effective for each patient.

Benefits of CAIX Targeted Therapy

Possible Side Effects

Most patients tolerate CAIX-targeted therapy well. Some mild side effects may occur, including:
1. Mild fatigue
2. Mild nausea
3. Temporary reduction in blood counts

These effects are usually temporary and manageable, and patients are closely monitored throughout treatment.

What Happens After Treatment?

Follow-up Monitoring Patients will have regular follow-up visits including:
1. Blood tests
2. Clinical evaluation
3. Follow-up imaging scans

These assessments help doctors determine how well the treatment is working.

Evaluation of Treatment Response

Follow-up scans may show whether tumors are:
1. Shrinking
2. Stable
3. Progressing

Based on these results, doctors will plan the next step in treatment.

Subsribe To Our Newsletter

Stay in touch with us to get latest news and special offers.

Address

Aster Whitefield Hospital Plot No. 3 & 4, Sadaramangala Industrial Area, off Whitefield Main Road, opposite ITPL, Whitefield, Bengaluru, Karnataka 560066

Call Us

+91 70223 10444

Email Us

prathapnuclearoncology@gmail.com